FDA NDC
Jentadueto XR
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 0597-0275
- Proprietary name
- Jentadueto XR
- Nonproprietary name
- linagliptin and metformin hydrochloride
- Labeler
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Strength
- 5 mg/1
Run it in Rivvi
Which 2027 plans near you dropped or restricted linagliptin and metformin hydrochloride?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.